Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Teladoc Health, Inc.TDOC · Entity 1547 | Director · CHIEF EXECUTIVE OFFICER | September 10, 2026 | September 14, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Teladoc Health, Inc.
Report date September 10, 2026 · Filed September 14, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 465,535 |
Ending reported balance
After 2026-09-11 transaction · row 3
3 source rows · reconciled sequenceRow 1 · 2026-09-10 · Exercise / conversion · Acquired 3,642 · Balance 444,180 F1: Performance stock units convert to shares of TDOC common stock on a one-for-one basis. Row 2 · 2026-09-10 · Exercise / conversion · Acquired 39,160 · Balance 483,340 F2: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. Row 3 · 2026-09-11 · Sale · Disposed 17,805 · Balance 465,535 F3: Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance stock unit and restricted stock unit awards. |
| Performance Stock UnitsSEC Table II · derivative / convertible security | Direct | 10,926 |
Reported balance
After 2026-09-10 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2026-09-10 · Exercise / conversion · Disposed 3,642 · Balance 10,926 F1: Performance stock units convert to shares of TDOC common stock on a one-for-one basis. F4: On June 10, 2026, the reporting person earned 23,591 performance stock units, vesting as to seven-twelfths on March 10, 2026, with the remainder vesting in five substantially equal quarterly installments over the subsequent 15 months. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 117,483 |
Reported balance
After 2026-09-10 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2026-09-10 · Exercise / conversion · Disposed 39,160 · Balance 117,483 F2: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. F5: On June 10, 2024, the reporting person was granted 469,924 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter. |
Filing footnotes · ownership attribution and instrument terms
F1: Performance stock units convert to shares of TDOC common stock on a one-for-one basis.
F2: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.
F3: Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance stock unit and restricted stock unit awards.
F4: On June 10, 2026, the reporting person earned 23,591 performance stock units, vesting as to seven-twelfths on March 10, 2026, with the remainder vesting in five substantially equal quarterly installments over the subsequent 15 months.
F5: On June 10, 2024, the reporting person was granted 469,924 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 11, 2026 Filed Sep 14, 2026 20:05 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 17,805 | $6.10 | $108,681.72 |
DisclosureSEC source: 0001347535-26-000011 · wk-form4_1789416301.xml · nonDerivative · entry 3 DIVITA CHARLES III · CIK 0001347535 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 465,535 F3 · shares: Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance stock unit and restricted stock unit awards. Read SEC document |
| September 10, 2026 Filed Sep 14, 2026 20:05 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionRestricted Stock Units · Derivative | 39,160 | $0.00 | $0.00 |
DisclosureSEC source: 0001347535-26-000011 · wk-form4_1789416301.xml · derivative · entry 5 DIVITA CHARLES III · CIK 0001347535 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 117,483 Underlying: Common Stock · 39,160 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. F5 · derivative.exercise_date: On June 10, 2024, the reporting person was granted 469,924 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter. F5 · derivative.expiration_date: On June 10, 2024, the reporting person was granted 469,924 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter. Read SEC document |
| September 10, 2026 Filed Sep 14, 2026 20:05 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionPerformance Stock Units · Derivative | 3,642 | $0.00 | $0.00 |
DisclosureSEC source: 0001347535-26-000011 · wk-form4_1789416301.xml · derivative · entry 4 DIVITA CHARLES III · CIK 0001347535 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,926 Underlying: Common Stock · 3,642 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Performance stock units convert to shares of TDOC common stock on a one-for-one basis. F4 · derivative.exercise_date: On June 10, 2026, the reporting person earned 23,591 performance stock units, vesting as to seven-twelfths on March 10, 2026, with the remainder vesting in five substantially equal quarterly installments over the subsequent 15 months. F4 · derivative.expiration_date: On June 10, 2026, the reporting person earned 23,591 performance stock units, vesting as to seven-twelfths on March 10, 2026, with the remainder vesting in five substantially equal quarterly installments over the subsequent 15 months. Read SEC document |
| September 10, 2026 Filed Sep 14, 2026 20:05 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 39,160 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001347535-26-000011 · wk-form4_1789416301.xml · nonDerivative · entry 2 DIVITA CHARLES III · CIK 0001347535 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 483,340 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| September 10, 2026 Filed Sep 14, 2026 20:05 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 3,642 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001347535-26-000011 · wk-form4_1789416301.xml · nonDerivative · entry 1 DIVITA CHARLES III · CIK 0001347535 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 444,180 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Performance stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| September 02, 2026 Filed Sep 3, 2026 20:05 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 18,327 | $6.30 | $115,478.43 |
DisclosureSEC source: 0001347535-26-000009 · wk-form4_1788465916.xml · nonDerivative · entry 3 DIVITA CHARLES III · CIK 0001347535 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 440,538 F3 · shares: Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance stock unit and restricted stock unit awards. Read SEC document |
| September 01, 2026 Filed Sep 3, 2026 20:05 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionPerformance Stock Units · Derivative | 1,966 | $0.00 | $0.00 |
DisclosureSEC source: 0001347535-26-000009 · wk-form4_1788465916.xml · derivative · entry 5 DIVITA CHARLES III · CIK 0001347535 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,795 Underlying: Common Stock · 1,966 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Performance stock units convert to shares of TDOC common stock on a one-for-one basis. F5 · derivative.exercise_date: On March 1, 2026, the reporting person earned 23,591 performance stock units, vesting one-third on March 1, 2026, with the remainder vesting in eight substantially equal quarterly installments thereafter. F5 · derivative.expiration_date: On March 1, 2026, the reporting person earned 23,591 performance stock units, vesting one-third on March 1, 2026, with the remainder vesting in eight substantially equal quarterly installments thereafter. Read SEC document |
| September 01, 2026 Filed Sep 3, 2026 20:05 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionRestricted Stock Units · Derivative | 42,277 | $0.00 | $0.00 |
DisclosureSEC source: 0001347535-26-000009 · wk-form4_1788465916.xml · derivative · entry 4 DIVITA CHARLES III · CIK 0001347535 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 253,662 Underlying: Common Stock · 42,277 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. F4 · derivative.exercise_date: On March 1, 2025, the reporting person was granted 507,322 restricted stock units, vesting one-third on March 1, 2026, with the remainder vesting in eight substantially equal quarterly installments thereafter. F4 · derivative.expiration_date: On March 1, 2025, the reporting person was granted 507,322 restricted stock units, vesting one-third on March 1, 2026, with the remainder vesting in eight substantially equal quarterly installments thereafter. Read SEC document |
| September 01, 2026 Filed Sep 3, 2026 20:05 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 1,966 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001347535-26-000009 · wk-form4_1788465916.xml · nonDerivative · entry 2 DIVITA CHARLES III · CIK 0001347535 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 458,865 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: Performance stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| September 01, 2026 Filed Sep 3, 2026 20:05 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 42,277 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001347535-26-000009 · wk-form4_1788465916.xml · nonDerivative · entry 1 DIVITA CHARLES III · CIK 0001347535 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 456,899 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| June 11, 2026 Filed Jun 12, 2026 20:05 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 18,074 | $6.94 | $125,469.71 |
DisclosureSEC source: 0001347535-26-000007 · wk-form4_1781294715.xml · nonDerivative · entry 3 DIVITA CHARLES III · CIK 0001347535 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 414,622 F3 · shares: Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance stock unit and restricted stock unit awards. Read SEC document |
| June 10, 2026 Filed Jun 12, 2026 20:05 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionRestricted Stock Units · Derivative | 39,160 | $0.00 | $0.00 |
DisclosureSEC source: 0001347535-26-000007 · wk-form4_1781294715.xml · derivative · entry 5 DIVITA CHARLES III · CIK 0001347535 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 156,643 Underlying: Common Stock · 39,160 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. F5 · derivative.exercise_date: On June 10, 2024, the reporting person was granted 469,924 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter. F5 · derivative.expiration_date: On June 10, 2024, the reporting person was granted 469,924 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter. Read SEC document |
| June 10, 2026 Filed Jun 12, 2026 20:05 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionPerformance Stock Units · Derivative | 3,642 | $0.00 | $0.00 |
DisclosureSEC source: 0001347535-26-000007 · wk-form4_1781294715.xml · derivative · entry 4 DIVITA CHARLES III · CIK 0001347535 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,568 Underlying: Common Stock · 3,642 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Performance stock units convert to shares of TDOC common stock on a one-for-one basis. F4 · derivative.exercise_date: On June 10, 2026, the reporting person earned 23,591 performance stock units, vesting as to seven-twelfths on March 10, 2026, with the remainder vesting in five substantially equal quarterly installments over the subsequent 15 months. F4 · derivative.expiration_date: On June 10, 2026, the reporting person earned 23,591 performance stock units, vesting as to seven-twelfths on March 10, 2026, with the remainder vesting in five substantially equal quarterly installments over the subsequent 15 months. Read SEC document |
| June 10, 2026 Filed Jun 12, 2026 20:05 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 39,160 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001347535-26-000007 · wk-form4_1781294715.xml · nonDerivative · entry 2 DIVITA CHARLES III · CIK 0001347535 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 432,696 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| June 10, 2026 Filed Jun 12, 2026 20:05 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 3,642 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001347535-26-000007 · wk-form4_1781294715.xml · nonDerivative · entry 1 DIVITA CHARLES III · CIK 0001347535 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 393,536 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Performance stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| June 02, 2026 Filed Jun 3, 2026 20:25 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 19,132 | $7.63 | $145,919.76 |
DisclosureSEC source: 0001347535-26-000006 · wk-form4_1780518304.xml · nonDerivative · entry 3 DIVITA CHARLES III · CIK 0001347535 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 389,894 F3 · shares: Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance stock unit and restricted stock unit awards. Read SEC document |
| June 01, 2026 Filed Jun 3, 2026 20:25 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionRestricted Stock Units · Derivative | 42,276 | $0.00 | $0.00 |
DisclosureSEC source: 0001347535-26-000006 · wk-form4_1780518304.xml · derivative · entry 5 DIVITA CHARLES III · CIK 0001347535 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 295,939 Underlying: Common Stock · 42,276 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. F5 · derivative.exercise_date: On March 1, 2025, the reporting person was granted 507,322 restricted stock units, vesting one-third on March 1, 2026, with the remainder vesting in eight substantially equal quarterly installments thereafter. F5 · derivative.expiration_date: On March 1, 2025, the reporting person was granted 507,322 restricted stock units, vesting one-third on March 1, 2026, with the remainder vesting in eight substantially equal quarterly installments thereafter. Read SEC document |
| June 01, 2026 Filed Jun 3, 2026 20:25 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionPerformance Stock Units · Derivative | 1,966 | $0.00 | $0.00 |
DisclosureSEC source: 0001347535-26-000006 · wk-form4_1780518304.xml · derivative · entry 4 DIVITA CHARLES III · CIK 0001347535 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,761 Underlying: Common Stock · 1,966 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Performance stock units convert to shares of TDOC common stock on a one-for-one basis. F4 · derivative.exercise_date: On March 1, 2026, the reporting person earned 23,591 performance stock units, vesting one-third on March 1, 2026, with the remainder vesting in eight substantially equal quarterly installments thereafter. F4 · derivative.expiration_date: On March 1, 2026, the reporting person earned 23,591 performance stock units, vesting one-third on March 1, 2026, with the remainder vesting in eight substantially equal quarterly installments thereafter. Read SEC document |
| June 01, 2026 Filed Jun 3, 2026 20:25 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 42,276 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001347535-26-000006 · wk-form4_1780518304.xml · nonDerivative · entry 2 DIVITA CHARLES III · CIK 0001347535 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 409,026 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| June 01, 2026 Filed Jun 3, 2026 20:25 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 1,966 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001347535-26-000006 · wk-form4_1780518304.xml · nonDerivative · entry 1 DIVITA CHARLES III · CIK 0001347535 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 366,750 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Performance stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| March 11, 2026 Filed Mar 12, 2026 20:06 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 27,731 | $5.49 | $152,243.19 |
DisclosureSEC source: 0001347535-26-000004 · wk-form4_1773345968.xml · nonDerivative · entry 3 DIVITA CHARLES III · CIK 0001347535 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 364,784 F3 · shares: Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance stock unit and restricted stock unit awards. Read SEC document |
| March 10, 2026 Filed Mar 12, 2026 20:06 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionPerformance Stock Units · Derivative | 25,493 | $0.00 | $0.00 |
DisclosureSEC source: 0001347535-26-000004 · wk-form4_1773345968.xml · derivative · entry 6 DIVITA CHARLES III · CIK 0001347535 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,210 Underlying: Common Stock · 25,493 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Performance stock units convert to shares of TDOC common stock on a one-for-one basis. F8 · derivative.exercise_date: On March 10, 2026, the reporting person earned 43,703 performance stock units, vesting seven-twelfths on March 10, 2026, with the remainder vesting in five substantially equal quarterly installments over the subsequent 15 months. F8 · derivative.expiration_date: On March 10, 2026, the reporting person earned 43,703 performance stock units, vesting seven-twelfths on March 10, 2026, with the remainder vesting in five substantially equal quarterly installments over the subsequent 15 months. Read SEC document |
| March 10, 2026 Filed Mar 12, 2026 20:06 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | GrantPerformance Stock Units · Derivative | 43,703 | $0.00 | $0.00 |
DisclosureSEC source: 0001347535-26-000004 · wk-form4_1773345968.xml · derivative · entry 5 DIVITA CHARLES III · CIK 0001347535 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 43,703 Underlying: Common Stock · 43,703 shares Expires not disclosed F5 · derivative.exercise_price: Each performance stock unit represents a contingent right to receive one share of TDOC common stock. F6 · shares: Performance award amount determined based on metrics in respect of the issuer's 2025 financial results. F7 · derivative.exercise_date: The performance stock units vest as to seven-twelfths on March 10, 2026, with the remainder vesting in five substantially equal quarterly installments over the subsequent 15 months. F7 · derivative.expiration_date: The performance stock units vest as to seven-twelfths on March 10, 2026, with the remainder vesting in five substantially equal quarterly installments over the subsequent 15 months. Read SEC document |
| March 10, 2026 Filed Mar 12, 2026 20:06 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionRestricted Stock Units · Derivative | 39,160 | $0.00 | $0.00 |
DisclosureSEC source: 0001347535-26-000004 · wk-form4_1773345968.xml · derivative · entry 4 DIVITA CHARLES III · CIK 0001347535 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 195,803 Underlying: Common Stock · 39,160 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. F4 · derivative.exercise_date: On June 10, 2024, the reporting person was granted 469,924 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter. F4 · derivative.expiration_date: On June 10, 2024, the reporting person was granted 469,924 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter. Read SEC document |
| March 10, 2026 Filed Mar 12, 2026 20:06 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 25,493 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001347535-26-000004 · wk-form4_1773345968.xml · nonDerivative · entry 2 DIVITA CHARLES III · CIK 0001347535 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 392,515 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: Performance stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| March 10, 2026 Filed Mar 12, 2026 20:06 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 39,160 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001347535-26-000004 · wk-form4_1773345968.xml · nonDerivative · entry 1 DIVITA CHARLES III · CIK 0001347535 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 367,022 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| March 02, 2026 Filed Mar 3, 2026 21:09 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 50,145 | $5.12 | $256,591.97 |
DisclosureSEC source: 0001347535-26-000002 · wk-form4_1772572168.xml · nonDerivative · entry 3 DIVITA CHARLES III · CIK 0001347535 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 327,862 F3 · shares: Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance stock unit and restricted stock unit awards. Read SEC document |
| March 01, 2026 Filed Mar 3, 2026 21:09 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | GrantRestricted Stock Units · Derivative | 692,041 | $0.00 | $0.00 |
DisclosureSEC source: 0001347535-26-000002 · wk-form4_1772572168.xml · derivative · entry 7 DIVITA CHARLES III · CIK 0001347535 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 692,041 Underlying: Common Stock · 692,041 shares Expires not disclosed F9 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of TDOC common stock. F10 · derivative.exercise_date: One-third of the restricted stock units vest on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter. F10 · derivative.expiration_date: One-third of the restricted stock units vest on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter. Read SEC document |
| February 27, 2026 Filed Mar 3, 2026 21:09 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionPerformance Stock Units · Derivative | 7,864 | $0.00 | $0.00 |
DisclosureSEC source: 0001347535-26-000002 · wk-form4_1772572168.xml · derivative · entry 6 DIVITA CHARLES III · CIK 0001347535 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,727 Underlying: Common Stock · 7,864 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Performance stock units convert to shares of TDOC common stock on a one-for-one basis. F8 · derivative.exercise_date: On March 1, 2026, the reporting person earned 23,591 performance stock units, vesting one-third on March 1, 2026, with the remainder vesting in eight substantially equal quarterly installments thereafter. F8 · derivative.expiration_date: On March 1, 2026, the reporting person earned 23,591 performance stock units, vesting one-third on March 1, 2026, with the remainder vesting in eight substantially equal quarterly installments thereafter. Read SEC document |
| February 27, 2026 Filed Mar 3, 2026 21:09 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | GrantPerformance Stock Units · Derivative | 23,591 | $0.00 | $0.00 |
DisclosureSEC source: 0001347535-26-000002 · wk-form4_1772572168.xml · derivative · entry 5 DIVITA CHARLES III · CIK 0001347535 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,591 Underlying: Common Stock · 23,591 shares Expires not disclosed F5 · derivative.exercise_price: Each performance stock unit represents a contingent right to receive one share of TDOC common stock. F6 · shares: Performance award amount determined based on metrics in respect of the issuer's 2025 financial results. F7 · derivative.exercise_date: The performance stock units vest as to one-third on March 1, 2026, with the remainder vesting in eight substantially equal quarterly installments thereafter. F7 · derivative.expiration_date: The performance stock units vest as to one-third on March 1, 2026, with the remainder vesting in eight substantially equal quarterly installments thereafter. Read SEC document |
| February 27, 2026 Filed Mar 3, 2026 21:09 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionRestricted Stock Units · Derivative | 169,107 | $0.00 | $0.00 |
DisclosureSEC source: 0001347535-26-000002 · wk-form4_1772572168.xml · derivative · entry 4 DIVITA CHARLES III · CIK 0001347535 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 338,215 Underlying: Common Stock · 169,107 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. F4 · derivative.exercise_date: On March 1, 2025, the reporting person was granted 507,322 restricted stock units, vesting one-third on March 1, 2026, with the remainder vesting in eight substantially equal quarterly installments thereafter. The reporting person's previous Form 4 filing incorrectly listed the number of restricted stock units granted as 507,332 instead of 507,322 due to a typo which has been corrected in this Form 4. F4 · derivative.expiration_date: On March 1, 2025, the reporting person was granted 507,322 restricted stock units, vesting one-third on March 1, 2026, with the remainder vesting in eight substantially equal quarterly installments thereafter. The reporting person's previous Form 4 filing incorrectly listed the number of restricted stock units granted as 507,332 instead of 507,322 due to a typo which has been corrected in this Form 4. Read SEC document |
| February 27, 2026 Filed Mar 3, 2026 21:09 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 7,864 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001347535-26-000002 · wk-form4_1772572168.xml · nonDerivative · entry 2 DIVITA CHARLES III · CIK 0001347535 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 378,007 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: Performance stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| December 11, 2025 Filed Dec 11, 2025 21:23 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 17,138 | $7.63 | $130,836.63 |
DisclosureSEC source: 0001347535-25-000007 · wk-form4_1765488183.xml · nonDerivative · entry 2 DIVITA CHARLES III · CIK 0001347535 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 201,036 F2 · kind: Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's restricted stock unit awards. Read SEC document |
| December 10, 2025 Filed Dec 11, 2025 21:23 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionRestricted Stock Units · Derivative | 39,160 | $0.00 | $0.00 |
DisclosureSEC source: 0001347535-25-000007 · wk-form4_1765488183.xml · derivative · entry 3 DIVITA CHARLES III · CIK 0001347535 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 234,963 Underlying: Common Stock · 39,160 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. F3 · derivative.exercise_date: On June 10, 2024, the reporting person was granted 469,924 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter. F3 · derivative.expiration_date: On June 10, 2024, the reporting person was granted 469,924 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter. Read SEC document |
| December 10, 2025 Filed Dec 11, 2025 21:23 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 39,160 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001347535-25-000007 · wk-form4_1765488183.xml · nonDerivative · entry 1 DIVITA CHARLES III · CIK 0001347535 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 218,174 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| September 11, 2025 Filed Sep 11, 2025 20:04 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 16,787 | $7.59 | $127,435.15 |
DisclosureSEC source: 0001347535-25-000005 · wk-form4_1757621047.xml · nonDerivative · entry 2 DIVITA CHARLES III · CIK 0001347535 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 179,014 F2 · kind: Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's restricted stock unit awards. Read SEC document |
| September 10, 2025 Filed Sep 11, 2025 20:04 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionRestricted Stock Units · Derivative | 39,160 | $0.00 | $0.00 |
DisclosureSEC source: 0001347535-25-000005 · wk-form4_1757621047.xml · derivative · entry 3 DIVITA CHARLES III · CIK 0001347535 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 274,123 Underlying: Common Stock · 39,160 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. F3 · derivative.exercise_date: On June 10, 2024, the reporting person was granted 469,924 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter. F3 · derivative.expiration_date: On June 10, 2024, the reporting person was granted 469,924 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter. Read SEC document |
| September 10, 2025 Filed Sep 11, 2025 20:04 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 39,160 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001347535-25-000005 · wk-form4_1757621047.xml · nonDerivative · entry 1 DIVITA CHARLES III · CIK 0001347535 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 195,801 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| June 10, 2025 Filed Jun 11, 2025 20:19 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionRestricted Stock Units · Derivative | 156,641 | $0.00 | $0.00 |
DisclosureSEC source: 0001347535-25-000003 · wk-form4_1749673145.xml · derivative · entry 2 DIVITA CHARLES III · CIK 0001347535 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 313,283 Underlying: Common Stock · 156,641 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. F2 · derivative.exercise_date: On June 10, 2024, the reporting person was granted 469,924 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter. F2 · derivative.expiration_date: On June 10, 2024, the reporting person was granted 469,924 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter. Read SEC document |
| June 10, 2025 Filed Jun 11, 2025 20:19 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 156,641 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001347535-25-000003 · wk-form4_1749673145.xml · nonDerivative · entry 1 DIVITA CHARLES III · CIK 0001347535 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 156,641 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| March 01, 2025 Filed Mar 4, 2025 21:06 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | GrantRestricted Stock Units · Derivative | 507,332 | $0.00 | $0.00 |
DisclosureSEC source: 0001477449-25-000015 · wk-form4_1741122349.xml · derivative · entry 1 DIVITA CHARLES III · CIK 0001347535 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 507,332 Underlying: Common Stock · 507,332 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of TDOC common stock. F2 · derivative.exercise_date: One-third of the restricted stock units vest on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter. F2 · derivative.expiration_date: One-third of the restricted stock units vest on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter. Read SEC document |
| June 10, 2024 Filed Jun 12, 2024 20:05 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | GrantRestricted Stock Units · Derivative | 469,924 | $0.00 | $0.00 |
DisclosureSEC source: 0001477449-24-000161 · wk-form4_1718222734.xml · derivative · entry 1 DIVITA CHARLES III · CIK 0001347535 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 469,924 Underlying: Common Stock · 469,924 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of TDOC common stock. F2 · derivative.exercise_date: One-third of the restricted stock units vest on June 10, 2025, with the remainder vesting in eight substantially equal quarterly installments thereafter. F2 · derivative.expiration_date: One-third of the restricted stock units vest on June 10, 2025, with the remainder vesting in eight substantially equal quarterly installments thereafter. Read SEC document |
| February 27, 2022 Filed Mar 3, 2026 21:09 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 169,107 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001347535-26-000002 · wk-form4_1772572168.xml · nonDerivative · entry 1 DIVITA CHARLES III · CIK 0001347535 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 370,143 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.